Login to Your Account

Trizytek Comes Home

Alnara Licenses Altus Cast-off Trizytek from CF Foundation

By Trista Morrison

Wednesday, March 25, 2009
Alnara Pharmaceuticals Inc. is expected to announce Wednesday morning that it has licensed the Phase III cystic fibrosis drug Trizytek - which was dropped by Altus Pharmaceuticals Inc. in January - from the Cystic Fibrosis Foundation. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription